GlaxoSmithKline PLC Director/PDMR Shareholding (9284A)
October 01 2015 - 7:07AM
UK Regulatory
TIDMGSK
RNS Number : 9284A
GlaxoSmithKline PLC
01 October 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibilities or Connected Persons
I give below details of changes in the Directors' interests in
the Ordinary Shares and American Depositary Shares ('ADSs') of
GlaxoSmithKline plc (the 'Company').
On 30 September 2015, the Company's Non-Executive Directors were
allocated notional Ordinary Shares at a price of GBP12.51 per
Ordinary Share, and notional ADSs at a price of $37.86 per ADS
under the share allocation arrangements for Non-Executive Directors
for the period of service from 1 July 2015 to 30 September
2015:
Non Executive Ordinary
Director Shares No. of ADSs
Sir Philip Hampton 3,497.202
Professor Sir
Roy Anderson 574.540
Dr Stephanie Burns 757.793
Stacey Cartwright 424.660
Lynn Elsenhans 1,552.170
Judy Lewent 587.943
Sir Deryck Maughan 1,829.157
Dr Daniel Podolsky 1,371.868
Urs Rohner 524.580
Hans Wijers 424.660
The Company and the Non-Executive Directors were informed of
these allocations on 1 October 2015.
This notification relates to transactions notified in accordance
with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 October 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFFLFBEBFBFBE
(END) Dow Jones Newswires
October 01, 2015 07:07 ET (11:07 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024